| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Sorafenib | CCLE | pan-cancer | AAC | 0.4 | 5e-20 |
| mRNA | VNLG/124 | GDSC1000 | pan-cancer | AAC | 0.18 | 5e-08 |
| mRNA | BRD-K71935468 | CTRPv2 | pan-cancer | AAC | 0.18 | 9e-07 |
| mRNA | Rapamycin | gCSI | pan-cancer | AAC | -0.26 | 1e-06 |
| mRNA | TKI258 | CCLE | pan-cancer | AAC | 0.2 | 8e-06 |
| mRNA | BRD-K94991378 | CTRPv2 | pan-cancer | AAC | 0.16 | 2e-05 |
| mRNA | dexamethasone | CTRPv2 | pan-cancer | AAC | -0.13 | 4e-05 |
| mRNA | AZD6244 | CCLE | pan-cancer | AAC | 0.17 | 7e-05 |
| mRNA | AICAR | GDSC1000 | pan-cancer | AAC | 0.12 | 0.0001 |
| mRNA | FR-180204 | GDSC1000 | pan-cancer | AAC | 0.13 | 0.0002 |